Piyaporn Srisura, Yuwaporn Pinyakit, Umphan Ngoensawat, Pongsakorn Yuntasiri, Khoiria Nur Atika Putri, Theerapat Chanamuangkon, Waranyoo Phoolcharoen, Varol Intasanta and Voravee P. Hoven
{"title":"Carboxymethyl cellulose-stabilized calcium phosphate particles for injectable hydrogel-based bone tissue engineering†","authors":"Piyaporn Srisura, Yuwaporn Pinyakit, Umphan Ngoensawat, Pongsakorn Yuntasiri, Khoiria Nur Atika Putri, Theerapat Chanamuangkon, Waranyoo Phoolcharoen, Varol Intasanta and Voravee P. Hoven","doi":"10.1039/D4SM00670D","DOIUrl":null,"url":null,"abstract":"<p >Calcium phosphate (CaP) is a widely used biocompatible and bioactive material for bone tissue engineering due to its similarity to the mineral component of natural bone. Amorphous calcium phosphate is a highly reactive form of CaP that can undergo a phase transformation into a more stable crystalline phase, making it an attractive candidate for bone regeneration applications. However, amorphous CaP is highly unstable in aqueous solutions, which limits its use in practical applications. To overcome this limitation, this research aimed to employ carboxymethyl cellulose (CMC), a water-soluble biopolymer, as a stabilizer for CaP particles. CMC can form a protective layer around CaP particles, enhancing their stability and dispersion in aqueous solutions. An <em>in situ</em> wet chemical process was used to prepare CaP/CMC particles. A concentration of 500 mg L<small><sup>−1</sup></small> of CMC was found to effectively stabilize the synthesized CaP particles, resulting in good dispersity. These particles were then integrated into an injectable hydrogel made of methacrylated hyaluronic acid (MeHA) to create a promising material for bone regeneration applications. The use of CaP and CMC in combination with an injectable MeHA hydrogel provides a promising approach to develop a stable, injectable material for bone regeneration.</p>","PeriodicalId":103,"journal":{"name":"Soft Matter","volume":" 44","pages":" 8824-8834"},"PeriodicalIF":2.9000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Soft Matter","FirstCategoryId":"92","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/sm/d4sm00670d","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Calcium phosphate (CaP) is a widely used biocompatible and bioactive material for bone tissue engineering due to its similarity to the mineral component of natural bone. Amorphous calcium phosphate is a highly reactive form of CaP that can undergo a phase transformation into a more stable crystalline phase, making it an attractive candidate for bone regeneration applications. However, amorphous CaP is highly unstable in aqueous solutions, which limits its use in practical applications. To overcome this limitation, this research aimed to employ carboxymethyl cellulose (CMC), a water-soluble biopolymer, as a stabilizer for CaP particles. CMC can form a protective layer around CaP particles, enhancing their stability and dispersion in aqueous solutions. An in situ wet chemical process was used to prepare CaP/CMC particles. A concentration of 500 mg L−1 of CMC was found to effectively stabilize the synthesized CaP particles, resulting in good dispersity. These particles were then integrated into an injectable hydrogel made of methacrylated hyaluronic acid (MeHA) to create a promising material for bone regeneration applications. The use of CaP and CMC in combination with an injectable MeHA hydrogel provides a promising approach to develop a stable, injectable material for bone regeneration.
磷酸钙(CaP)与天然骨骼中的矿物质成分相似,是一种广泛应用于骨组织工程的生物相容性和生物活性材料。无定形磷酸钙是 CaP 的一种高活性形式,它可以发生相变,变成更稳定的结晶相,因此成为骨再生应用的一种有吸引力的候选材料。然而,无定形 CaP 在水溶液中极不稳定,这限制了它在实际应用中的使用。为了克服这一限制,本研究旨在采用水溶性生物聚合物羧甲基纤维素(CMC)作为 CaP 颗粒的稳定剂。CMC 可在 CaP 粒子周围形成保护层,增强其在水溶液中的稳定性和分散性。采用原位湿化学工艺制备 CaP/CMC 颗粒。结果发现,浓度为 500 mg L-1 的 CMC 能有效稳定合成的 CaP 粒子,使其具有良好的分散性。然后,这些颗粒被整合到由甲基丙烯酸化透明质酸(MeHA)制成的可注射水凝胶中,形成了一种具有骨再生应用前景的材料。将 CaP 和 CMC 与可注射的 MeHA 水凝胶结合使用,为开发稳定、可注射的骨再生材料提供了一种可行的方法。